Omicron BA.2 Subvariant is More Transmissible

Omicron BA.2 subvariant seems to be more transmissible than BA.1. It also possesses immune-evasive properties that further reduce the protective effect of vaccination against infection. 

On 26 November 2021, WHO had designated B.1.1.529 variant of SARS-CoV-2 as a Variant of concern (VOC), and named Omicron.  

As on date, Omicron includes Pango lineage B.1.1.529 and descendent Pango lineages BA.1, BA.1.1, BA.2 and BA.3. The defining mutations fully overlaps with the lineage BA.1. The descendent lineage BA.2 differs from BA.1 in some of the mutations, including in the spike protein.  

BA.2 variant is increasing in many countries. In several countries, two Omicron subvariants are observed BA.1 and BA.2. 

In Denmark, BA.2 has rapidly replaced BA.1 and has become the dominant subvariant. In a recent nationwide study of Danish households, the secondary attack rate (SAR) was estimated as 29% and 39% in households infected with Omicron BA.1 and BA.2, respectively.  

BA.2 was found to be associated with an increased susceptibility of infection for unvaccinated individuals (Odds Ratio 2.19), fully vaccinated individuals (OR 2.45) and booster-vaccinated individuals (OR 2.99), compared to BA.1.  

The researchers also found an increased transmissibility from unvaccinated primary cases in BA.2 households when compared to BA.1 households. The pattern of increased transmissibility in BA.2 households was not observed for fully vaccinated and booster-vaccinated primary cases.   

In conclusion, Omicron BA.2 subvariant seems to be more transmissible than BA.1. It also possesses immune-evasive properties that further reduce the protective effect of vaccination against infection.  

***

Sources:  

  1. WHO 2022. Tracking SARS-CoV-2 variants. Available at https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ Accessed on 04 February 2022.  
  1. Lyngse FP, et al 2022. Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish Households. Preprint medRxiv. Posted January 30, 2022. DOI: https://doi.org/10.1101/2022.01.28.22270044 

***

Latest

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Newsletter

Don't miss

Neuralink: A Next Gen Neural Interface That Could Change Human Lives

Neuralink is an implantable device that has shown significant...

Enhancing Drug Efficiency by Correcting 3D Orientation of Molecules

Researchers have discovered a way to design efficient medicines...

Antimicrobial resistance (AMR): a novel antibiotic Zosurabalpin (RG6006) shows promise in pre-clinical trials

Antibiotic resistance particularly by Gram-negative bacteria has nearly created a...

Search of Life Beyond Earth: Clipper Mission to Europa Launched  

NASA has successfully launched Clipper mission to Europa into...

Genetics of COVID-19: Why Some People Develop Severe Symptoms

Advanced age and comorbidities are known to be high...

What caused the Mysterious Seismic Waves Recorded in September 2023 

In September 2023, uniform single frequency seismic waves were...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both strategic investment and active contribution in shaping its future direction.  Scientific European is an England-based media outlet providing multilingual...